Best of ASCO - 2014 Annual Meeting

 

Welcome

Disparities/Access to Care

Health Services Research, Clinical Informatics, and Quality of Care

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A novel patient-centric approach between sites, CRO, and sponsor to accelerate FPI and drive more patients into oncology protocols.

Krystyna Kowalczyk

6573

Acceptability of mobile health technology among cancer patients.

Rashmika Potdar

e18139

Access to care and financial burden for patients with breast cancer in Ghana, Kenya, and Nigeria.

Majid Twahir

6562

Affordable Care Act (ACA) Medicaid expansion impact on racial disparities in time to cancer treatment.

Blythe J.S. Adamson

LBA1

Arabic and Assyrian immigrants’ knowledge of hepatitis and liver cancer in Sydney, Australia. Findings of a community consultation process.

Monica Cristina Robotin

e18167

Are racial differences in obesity and insulin resistance related to aggressive breast cancer?

Emily Gallagher

e18157

Are two sites better than one?: Sites of care and quality of myeloma treatment.

Anne Renteria

e18159

Assessment of enrollment characteristics for Children’s Oncology Group (COG) upfront therapeutic clinical trials 2004-2015.

Kelly Faulk

6564

Association of diagnosing physician and hospital characteristics with the use of radical cystectomy among patients with muscle-invasive bladder cancer.

Hemalkumar B Mehta

6576

Association of state Medicaid expansion with timeliness of cancer care delivery.

Samuel U Takvorian

e18126

Australian population-based study of single- versus multi-fraction palliative radiotherapy for bone metastases.

Wee Loon Ong

6568

Barriers and facilitators to oncology clinical trial accrual: Comparing perceptions of community and academic oncologists.

Andrew R. Wong

e18131

Barriers to clinical trial accrual: Clinical trialists' perspectives.

Edward S. Kim

e18156

Barriers to clinical trial enrollment of older adults with cancer: A systematic review.

Mina S. Sedrak

e18130

Biomarker testing, treatment (Tx) and survival outcomes in Medicaid compared to commercially insured (CI) patients with advanced NSCLC (aNSCLC).

Yeun Mi Yim

e18119

Body composition change, safety, and efficacy with everolimus use in ethnic minorities with breast cancer.

Gurbakhash Kaur

e18145

Building international partnerships to improve global oncological care: Perspective from Rutgers-CINJ Global Oncology Fellowship Program.

Ashwin Chandar

e18161

Cancer patients experiencing homelessness: What’s happening to them?

Brian Stewart Bingham

e18153

Cervical cancer screening in incarcerated women: An experience from the first cervical cancer screening campaign in a southern Thailand correctional facility.

Ingporn Jiamset

6572

Clinical impact of the Mexican healthcare system "Seguro Popular" on breast cancer survival.

Luis Antonio Cancel

6569

Clinical responses and survival in Hispanic patients with non-small cell lung cancer treated with immunotherapy compared with non-Hispanic whites.

Luis E. Raez

e18109

Comparable survival of African-Americans and Caucasian patients with multiple myeloma: A hospital-based study including 117,926 patients.

Ehsan Malek

e18170

Contextualizing place and health in rural America: Cancer information seeking across four categories of an urban/rural continuum.

Gilberto Lopez

e18124

Contributive compared with subsidized insurance in colorectal cancer in the Colombian National Administrative Cancer Registry.

Robert Hsu

e18136

Delays in diagnosis in young patients with leukemia and lymphoma.

Lena Winestone

e18138

Development of a financial navigation program to ease the burden of financial toxicity.

Melissa Monak

6565

Diagnostic and treatment delays in young women with breast cancer.

Philip D Poorvu

6575

Disparities in survival by insurance status in chronic lymphocytic leukemia.

Kahee A. Mohammed

e18134

Disparities in the receipt of palliative care (PC) in metastatic renal cell carcinoma (mRCC).

Sri Harsha Tella

e18108

Effectiveness of mobile computerized tomographic (CT) lung scanning unit for early diagnosis of lung cancer in under-served populations.

Derek Raghavan

6567

Enrollment disparities in cancer clinical trials: A single institution experience.

Ariel Perez Perez

e18128

Esophageal cancer in Hispanic patients: A demographic analysis of the National Cancer Database.

Juan Ricardo

6561

Evaluating use of interpreters in educating immigrants on cancer prevention and screening guidelines.

Linda Bulone

e18149

Evaluation of racial disparities in the treatment of United States veterans with pancreatic cancer.

Theodore Seth Thomas

e18148

Examining predictors of female cancer treatment delay in Appalachian women.

Rajesh Balkrishnan

e18107

Expanded access for cancer patients: The 5-year FDA CBER experience.

Laronna S. Colbert

e18158

Experience and challenges of setting up a new lung cancer chemotherapy clinic in resource limited setting in Nepal.

Deebya Raj Mishra

e18104

FDA analysis: Demographic trends in bladder and renal cancer trials.

Laura L Fernandes

e18144

Forecasting the global need for high-dose methotrexate to prevent and mitigate shortages.

Scott C. Howard

6571

Healthcare disparities among cancer patients in the emergency department: How do race and ethnicity affect bounce-back rates?

Christopher John Coyne

e18150

Impact of a pilot patient navigator program on pediatric cancer outcomes in a low resource setting.

Kristin Schroeder

e18152

Impact of a same-day breast biopsy program on disparities in time to biopsy.

Matthew Seidler

6508

Impact of broadening clinical trial eligibility criteria for advanced non-small cell lung cancer patients: Real-world analysis.

R. Donald Harvey

LBA108

Impact of dual anti-HER2 therapy on pathologic complete response rate in breast cancer in a minority-enriched population.

Jenny Jing Li

e18111

Impact of race/ethnicity in the clinical presentation and outcomes of patients with multiple myeloma in an underserved urban population.

Christian Torres

6570

Impact of the Affordable Care Act on insurance for adolescents and young adults with cancer.

Lena Winestone

e18125

Impact of travel time on healthcare costs and resource utilization by phase of care for older cancer patients.

Gabrielle Betty Rocque

6560

Improved hepatocellular carcinoma (HCC) outcomes in a public hospital setting with increased access to procedural-based therapy.

Elizabeth S. Ellent

e18137

Incidence patterns of early onset colon cancer by race and stage in the US.

Nishi Shah

e18168

Insurance status and racial disparities in detection of early-stage breast cancer.

Naomi Ko

e18121

Investigating racial differences in treatment responses through analysis of real-world data (RWD).

Zongzhi Liu

e18141

Investigation of HBOC germline mutations in women diagnosed with breast cancer in Trinidad and Tobago.

Gerneiva Parkinson

6574

Liver cancer systemic treatment patterns in the largely rural state of New Mexico.

Natalia Cadavid

e18166

Lower survival outcomes in patients receiving an initial cancer diagnosis after presenting to the emergency department.

Hannah L. Conley

e18122

Modeling accrual of older adults to cancer clinical trials: (Alliance A151736).

Noam Avraham VanderWalde

e18132

Participation of African Americans in clinical trials supporting FDA approval of cancer drugs.

Samer Al Hadidi

e18135

Patient related outcomes in cancer patients in Croatia.

Dragan Trivanovic

TPS6650

Patient’s insurance status impact on biomarker testing in the United States market.

Daniel F. Winkelman

e18114

Prescription patterns and associated cost during periods of cancer drug stockouts in a resource-limited setting.

Sonya Davey

e18129

Quality of end-of-life cancer care at minority-serving US cancer centers: A retrospective study of Medicare claims data.

Garrett Wasp

6507

Race as an independent factor for survival in breast cancer patients according to analysis of the National Cancer Database (NCDB).

Drew Carl Drennan Murray

e18155

Racial and insurance disparities in multiple myeloma management in a referral center.

Anne Renteria

e18140

Racial and socioeconomic disparities in follicular lymphoma survival.

Richard Stephen Sheppard

e18173

Racial comparisons in receipt of timely guideline-based colon cancer treatment in an equal-access health system.

Yvonne L Eaglehouse

6563

Racial differences in intravenous bisphosphonate utilization among older patients with multiple myeloma.

Jifang Zhou

e18165

Racial disparities in setting of care in women with breast cancer in South Carolina.

McKenzie Sorrell

e18146

Rates and patterns of uninsured cancer survivors before and after implementation of the Affordable Care Act, 2000-2017.

Nina Niu Sanford

e18105

Reassessing existing expanded access programs and planning forward in the time of Right to Try.

Anne Cropp

e18172

Socioeconomic disparities among uninsured cancer patients: A free clinic study.

Madeline MacDonald

e18110

Survey of medical student knowledge in oncology and survivorship care in Nigeria: A pilot study.

Jim Leng

e18106

Survival trends in elderly patients with malignant mesothelioma: An analysis utilizing Surveillance, Epidemiology, and End Results database.

Lubina Arjyal

e18164

The Affordable Care Act and cost-related medication non-compliance in cancer survivors.

Justin Barnes

106

The impact of ACA on medical financial hardship among cancer survivors.

Aaron N Winn

e18160

The impact of race and socioeconomic status on outcomes for HPV-associated squamous cell carcinoma of the head and neck.

Luke Roy George Pike

e18103

Time matters: A retrospective study of cancer care in a Brazilian public university hospital.

Camila Brambilla Souza

e18171

Timeliness of treatment for patients referred urgently with a high suspicion of cancer in New Zealand.

Rob McNeill

e18147

Unique perspectives from the transgender community: A retrospective chart review of cancer care needs for transgender patients.

Carolyn Moloney

6566

Which social measures relate to cancer screening & healthy behaviors?

Kezhen Fei

e18142

Worse outcomes associated with public insurance at sarcoma diagnosis in adolescent and young adults (AYAs).

Elysia Marie Alvarez

e18143